Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

DAVID J MOONEY

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1831350198
CMS profile
1212878
Location
BIRMINGHAM, AL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$7,218.75

284 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $5,153.36 278
Consulting Fee $2,012.50 3
Education $52.89 3

By paying entity

PY2022 · entire year · sorted by reported total

Paying entityAmountRecords
OnMark, Inc. $2,012.50 3
Novartis Pharmaceuticals Corporation $500.01 32
E.R. Squibb & Sons, L.L.C. $457.52 29
PFIZER INC. $317.69 18
Celgene Corporation $213.71 12
Amgen Inc. $207.26 11
Janssen Biotech, Inc. $204.94 12
Daiichi Sankyo Inc. $201.95 9
Merck Sharp & Dohme LLC $188.96 10
Seagen Inc. $179.44 11
NuVasive, Inc. $170.56 2
US Oncology Corporate, Inc. $164.32 4
Genentech USA, Inc. $152.75 9
Lilly USA, LLC $139.66 9
GENZYME CORPORATION $137.11 6
Incyte Corporation $134.95 7
ABBVIE INC. $127.38 7
EISAI INC. $126.68 6
Global Blood Therapeutics, Inc. $98.29 6
AstraZeneca Pharmaceuticals LP $87.85 6
GlaxoSmithKline, LLC. $84.32 4
Alexion Pharmaceuticals, Inc. $82.18 5
Sobi, Inc $79.95 4
Epizyme, Inc., $77.85 4
Deciphera Pharmaceuticals Inc. $72.60 4
Bayer HealthCare Pharmaceuticals Inc. $65.83 3
Progenics Pharmaceuticals, Inc. $65.38 3
Regeneron Healthcare Solutions, Inc. $64.44 3
JAZZ PHARMACEUTICALS INC. $57.87 3
Karyopharm Therapeutics Inc. $53.64 3
Gilead Sciences, Inc. $52.02 3
BeiGene USA, Inc. $51.27 3
Boehringer Ingelheim Pharmaceuticals, Inc. $50.39 2
ARRAY BIOPHARMA INC $47.40 4
Takeda Pharmaceuticals U.S.A., Inc. $46.08 3
Kite Pharma, Inc. $45.00 3
CTI BioPharma Corp. $40.13 2
AVEO Pharmaceuticals, Inc. $39.15 2
Exelixis Inc. $38.08 2
CSL Behring $37.38 1
Acrotech Biopharma LLC $32.52 2
Ipsen Biopharmaceuticals, Inc $24.98 1
Rigel Pharmaceuticals, Inc. $24.05 1
TerSera Therapeutics LLC $22.11 1
MorphoSys, US Inc. $19.07 1
Myriad Genetic Laboratories, Inc. $18.33 1
Myovant Sciences Inc. $16.51 1
ADC Therapeutics America, Inc. $16.46 1
EMD Serono, Inc. $16.14 1
Taiho Oncology, Inc. $14.12 1
Pharmacyclics LLC, an AbbVie Company $13.99 1
Mylan Institutional Inc. $13.48 1
PUMA BIOTECHNOLOGY, INC. $12.50 1

Page 4 of 6; records 151–200 of 284 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

DAVID J MOONEY

NPI 1831350198 · CMS profile ID 1212878

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

BIRMINGHAM, AL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 4 of 6; records 151–200 of 284 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1831350198?year=2022&recipient=provider&page=4#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
DAVID J MOONEY, NPI 1831350198, CMS profile ID 1212878. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 6; records 151–200 of 284 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1831350198?year=2022&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). DAVID J MOONEY, NPI 1831350198, CMS profile ID 1212878. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 6; records 151–200 of 284 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1831350198?year=2022&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
DAVID J MOONEY, NPI 1831350198, CMS profile ID 1212878, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 4 of 6; records 151–200 of 284 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1831350198?year=2022&recipient=provider&page=4#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

284 matching records · $7,218.75 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 284 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 151–200 of 284.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Global Blood Therapeutics, Inc. $14.6206/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 942699075 CMS
Incyte Corporation $20.1306/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 943035311 CMS
Amgen Inc. $20.3906/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939892967 CMS
Genentech USA, Inc. $19.9506/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 950771001 CMS
AstraZeneca Pharmaceuticals LP $13.6806/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914838595 CMS
Novartis Pharmaceuticals Corporation $20.3606/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893990079 CMS
Daiichi Sankyo Inc. $27.7606/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930847537 CMS
EISAI INC. $14.0506/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908030405 CMS
Merck Sharp & Dohme LLC $19.9506/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944175777 CMS
Merck Sharp & Dohme LLC $18.4806/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944185727 CMS
E.R. Squibb & Sons, L.L.C. $16.4506/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932749331 CMS
E.R. Squibb & Sons, L.L.C. $18.7706/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932749325 CMS
E.R. Squibb & Sons, L.L.C. $18.8206/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932749321 CMS
E.R. Squibb & Sons, L.L.C. $1.5306/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932749323 CMS
Epizyme, Inc., $24.3106/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917609937 CMS
Seagen Inc. $14.7506/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 904108831 CMS
Amgen Inc. $19.2805/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939892957 CMS
PFIZER INC. $17.3605/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949133685 CMS
Lilly USA, LLC $13.3905/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918047673 CMS
Bayer HealthCare Pharmaceuticals Inc. $23.9305/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929810595 CMS
Takeda Pharmaceuticals U.S.A., Inc. $17.1005/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 955741863 CMS
E.R. Squibb & Sons, L.L.C. $15.7405/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932749421 CMS
Myovant Sciences Inc. $16.5105/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 941226337 CMS
Novartis Pharmaceuticals Corporation $10.2105/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893990077 CMS
Deciphera Pharmaceuticals Inc. $12.2905/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 953435041 CMS
Novartis Pharmaceuticals Corporation $15.1805/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893990069 CMS
Novartis Pharmaceuticals Corporation $15.7605/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893990073 CMS
ABBVIE INC. $24.0105/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891195539 CMS
Kite Pharma, Inc. $19.7005/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920061469 CMS
Sobi, Inc $22.5905/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940364835 CMS
Progenics Pharmaceuticals, Inc. $26.8205/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938567227 CMS
Seagen Inc. $19.3505/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 904108887 CMS
PUMA BIOTECHNOLOGY, INC. $12.5005/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 942291239 CMS
AstraZeneca Pharmaceuticals LP $13.1905/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915832649 CMS
Celgene Corporation $17.7205/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932749319 CMS
Lilly USA, LLC $16.2505/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917965791 CMS
Janssen Biotech, Inc. $22.9205/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885467419 CMS
NuVasive, Inc. $142.4205/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 948924951 CMS
PFIZER INC. $11.8405/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949120293 CMS
E.R. Squibb & Sons, L.L.C. $21.7605/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932749317 CMS
Merck Sharp & Dohme LLC $16.8105/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944161659 CMS
Seagen Inc. $14.1204/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 904108823 CMS
BeiGene USA, Inc. $16.4704/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940791053 CMS
Deciphera Pharmaceuticals Inc. $23.3504/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 953435039 CMS
MorphoSys, US Inc. $19.0704/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 962536689 CMS
ABBVIE INC. $17.4104/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891195537 CMS
Merck Sharp & Dohme LLC $19.1904/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944157133 CMS
E.R. Squibb & Sons, L.L.C. $17.1404/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932749313 CMS
E.R. Squibb & Sons, L.L.C. $15.6304/21/2022 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932749307 CMS
Novartis Pharmaceuticals Corporation $15.8404/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893990065 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $4,449.32 267
PY2020 $6,256.69 181
PY2021 $4,607.23 223
PY2022 $7,218.75 284
PY2023 $14,820.01 240
PY2024 $37,254.62 264
PY2025 $45,621.49 259

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $287,999.25 3
PY2024 Principal investigator $673,792.45 1
PY2023 Principal investigator $533,044.15 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

3 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Celgene Corporation $16,200.00 10/29/2025 Non-covered Recipient Entity
Central Alabama Research
A Phase 3, Two-part, Randomized, Open-label, Adaptive Study Comparing BMS-986365 versus Investigators Choice of Therapy Comprising Either Docetaxel or Second Androgen Receptor Pathway Inhibitor (ARPI), in Participants with Metastatic Castration-resistant Prostate Cancer (mCRPC) - rechARge No dispute reported 06/30/2026 1222306130
Principal investigator 1 Novartis Pharmaceuticals Corporation $43,271.85 10/28/2025 Non-covered Recipient Entity
HEMATOLOGY AND ONCOLOGY ASSOCIATES OF ALABAMA, LLC
A Phase IIIb Study to Characterize the Effectiveness and Safety of Adjuvant Ribociclib in a Wide Patient Population With HR+ HER2- Early Breast Cancer (Adjuvant WIDER) No dispute reported 06/30/2026 1190301279
Principal investigator 1 AstraZeneca UK Limited $228,527.40 01/13/2025 Non-covered Recipient Entity
CENTRAL ALABAMA RESEARCH
A Phase I-III Randomized Double blind Study to Evaluate the Safety and Neutralizing Activity of AZD5156-AZD3152 for Pre exposure Prophylaxis of COVID 19 in Participants with Conditions Causing Immune Impairment No dispute reported 06/30/2026 1185556025